These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Updates in the Metabolic Management of Calcium Stones. Penniston KL; Nakada SY Curr Urol Rep; 2018 Apr; 19(6):41. PubMed ID: 29663088 [TBL] [Abstract][Full Text] [Related]
5. Evaluation and medical management of the patient with calcium stone disease. Menon M; Krishnan CS Urol Clin North Am; 1983 Nov; 10(4):595-615. PubMed ID: 6636376 [TBL] [Abstract][Full Text] [Related]
6. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy. Pak CY; Sakhaee K; Fuller CJ Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957 [TBL] [Abstract][Full Text] [Related]
7. Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients. Strauss AL; Coe FL; Parks JH Arch Intern Med; 1982 Mar; 142(3):504-7. PubMed ID: 7065787 [TBL] [Abstract][Full Text] [Related]
8. Evaluation and management of dietary habits in Japanese renal stone formers. Ito H; Kotake T; Miura N Scanning Microsc; 1993 Mar; 7(1):409-14; discussion 414-5. PubMed ID: 8316810 [TBL] [Abstract][Full Text] [Related]
9. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. Taylor EN; Stampfer MJ; Curhan GC J Am Soc Nephrol; 2004 Dec; 15(12):3225-32. PubMed ID: 15579526 [TBL] [Abstract][Full Text] [Related]
10. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation. Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the kidney stone patient. Asplin JR Semin Nephrol; 2008 Mar; 28(2):99-110. PubMed ID: 18359391 [TBL] [Abstract][Full Text] [Related]
12. [Dietetic approach to renal lithiasis]. Sakly R; Achour A Ann Urol (Paris); 1991; 25(5):237-41. PubMed ID: 1776871 [TBL] [Abstract][Full Text] [Related]
13. Critical evaluation of various forms of therapy for idiopathic calcium stone disease. Marangella M; Tricerri A; Sonego S; Ronzani M; Fruttero B; Daniele PG; Bruno M; Linari F Proc Eur Dial Transplant Assoc; 1983; 20():434-9. PubMed ID: 6361754 [TBL] [Abstract][Full Text] [Related]
16. Tea and coffee as the main sources of oxalate in diets of patients with kidney oxalate stones. Gasińska A; Gajewska D Rocz Panstw Zakl Hig; 2007; 58(1):61-7. PubMed ID: 17711092 [TBL] [Abstract][Full Text] [Related]
17. Space flight and the risk of renal stones. Whitson PA; Pietrzyk RA; Sams CF J Gravit Physiol; 1999 Jul; 6(1):P87-8. PubMed ID: 11543039 [TBL] [Abstract][Full Text] [Related]
18. Is there a risk for kidney stone formation in cystic fibrosis? Böhles H; Michalk D Helv Paediatr Acta; 1982 Jun; 37(3):267-72. PubMed ID: 7118558 [TBL] [Abstract][Full Text] [Related]
19. Clinical and laboratory evaluation of renal stone patients. Wilson DM Endocrinol Metab Clin North Am; 1990 Dec; 19(4):773-803. PubMed ID: 2081511 [TBL] [Abstract][Full Text] [Related]
20. Outcome of metabolic evaluation and medical treatment for calcium nephrolithiasis in a private urological practice. Mardis HK; Parks JH; Muller G; Ganzel K; Coe FL J Urol; 2004 Jan; 171(1):85-8. PubMed ID: 14665850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]